Amemiya Shimon, Hamamoto Makoto, Kumagai Tomoaki, Ueda Masayuki, Katayama Yasuo, Tanaka Keiko
Division of Neurology, Internal Medicine, Nippon Medical School, Tokyo, Japan.
J Neuroimaging. 2009 Jul;19(3):263-5. doi: 10.1111/j.1552-6569.2008.00288.x. Epub 2008 Aug 4.
Neuromyelitis optica (NMO) is considered a distinct disease from multiple sclerosis (MS) because of its pathogenesis. It is well accepted that NMO selectively affects the spinal cord and optic nerve and is not associated with brain lesions at the onset of the disease, unlike MS. We present a unique case where the patient's initial lesion was in the brain, and optic neuritis and myelitis were revealed 6 years after the brain lesion. In addition, the patient's serum antiaquaporin 4 (AQP4) antibody was positive. We consider the brain lesion to precede abnormal lesion of NMO, and the AQP4 measurement is important for diagnostics, even if it occurs with brain lesions.
视神经脊髓炎(NMO)因其发病机制被认为是一种与多发性硬化症(MS)不同的疾病。与MS不同,NMO选择性地影响脊髓和视神经,且在疾病发作时不伴有脑部病变,这一点已得到广泛认可。我们报告了一例独特病例,该患者最初的病变位于脑部,脑部病变6年后出现视神经炎和脊髓炎。此外,患者血清抗水通道蛋白4(AQP4)抗体呈阳性。我们认为脑部病变先于NMO的异常病变出现,即使伴有脑部病变,AQP4检测对于诊断也很重要。